Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 245

1.

Heart Failure: Diagnosis, Management and Utilization.

Inamdar AA, Inamdar AC.

J Clin Med. 2016 Jun 29;5(7). pii: E62. doi: 10.3390/jcm5070062. Review.

2.

Complex cardiac pacing in the setting of a district general hospital: procedural success and complications.

Rahbi H, El-Din M, Salloum M, Shaukat N, Farooq M.

Heart Asia. 2014 Jun 24;6(1):94-9. doi: 10.1136/heartasia-2013-010421. eCollection 2014.

3.

Spotlight on valsartan-sacubitril fixed-dose combination for heart failure: the evidence to date.

Vilela-Martin JF.

Drug Des Devel Ther. 2016 May 9;10:1627-39. doi: 10.2147/DDDT.S84782. eCollection 2016. Review.

4.

Heart Failure Clinical Trials in East and Southeast Asia: Understanding the Importance and Defining the Next Steps.

Mentz RJ, Roessig L, Greenberg BH, Sato N, Shinagawa K, Yeo D, Kwok BW, Reyes EB, Krum H, Pieske B, Greene SJ, Ambrosy AP, Kelly JP, Zannad F, Pitt B, Lam CS.

JACC Heart Fail. 2016 Jun;4(6):419-27. doi: 10.1016/j.jchf.2016.01.013. Review.

PMID:
27256745
5.

Discovery of Genetic Variation on Chromosome 5q22 Associated with Mortality in Heart Failure.

Smith JG, Felix JF, Morrison AC, Kalogeropoulos A, Trompet S, Wilk JB, Gidlöf O, Wang X, Morley M, Mendelson M, Joehanes R, Ligthart S, Shan X, Bis JC, Wang YA, Sjögren M, Ngwa J, Brandimarto J, Stott DJ, Aguilar D, Rice KM, Sesso HD, Demissie S, Buckley BM, Taylor KD, Ford I, Yao C, Liu C; CHARGE-SCD consortium; EchoGen consortium; QT-IGC consortium; CHARGE-QRS consortium, Sotoodehnia N, van der Harst P, Stricker BH, Kritchevsky SB, Liu Y, Gaziano JM, Hofman A, Moravec CS, Uitterlinden AG, Kellis M, van Meurs JB, Margulies KB, Dehghan A, Levy D, Olde B, Psaty BM, Cupples LA, Jukema JW, Djousse L, Franco OH, Boerwinkle E, Boyer LA, Newton-Cheh C, Butler J, Vasan RS, Cappola TP, Smith NL.

PLoS Genet. 2016 May 5;12(5):e1006034. doi: 10.1371/journal.pgen.1006034. eCollection 2016 May.

7.

To Revascularise or Not To Revascularise, That Is the Question: the Diagnostic and Management Conundrum of Ischaemic Cardiomyopathy.

Briceno N, Perera D.

Curr Cardiol Rep. 2016 Jun;18(6):54. doi: 10.1007/s11886-016-0726-9. Review.

8.

Translational neurocardiology: preclinical models and cardioneural integrative aspects.

Ardell JL, Andresen MC, Armour JA, Billman GE, Chen PS, Foreman RD, Herring N, O'Leary DS, Sabbah HN, Schultz HD, Sunagawa K, Zucker IH.

J Physiol. 2016 Jul 15;594(14):3877-909. doi: 10.1113/JP271869. Epub 2016 Jun 17.

PMID:
27098459
9.

Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis.

Kotecha D, Manzano L, Krum H, Rosano G, Holmes J, Altman DG, Collins PD, Packer M, Wikstrand J, Coats AJ, Cleland JG, Kirchhof P, von Lueder TG, Rigby AS, Andersson B, Lip GY, van Veldhuisen DJ, Shibata MC, Wedel H, Böhm M, Flather MD; Beta-Blockers in Heart Failure Collaborative Group.

BMJ. 2016 Apr 20;353:i1855. doi: 10.1136/bmj.i1855. Review.

10.

Chronic Heart Failure Clinical Practice Guidelines' Class 1-A Pharmacologic Recommendations: Start-to-End Synergistic Drug Therapy?

Abarquez RF Jr, Reganit PF, Chungunco CN, Alcover J, Punzalan FE, Reyes EB, Cunanan EL.

ASEAN Heart J. 2016 Mar 8;24:4. eCollection 2016 Mar.

11.

Does modern medicine increase life-expectancy: Quest for the Moon Rabbit?

Mishra S.

Indian Heart J. 2016 Jan-Feb;68(1):19-27. doi: 10.1016/j.ihj.2016.01.003. Epub 2016 Jan 18.

12.

"Nihilism" of chronic heart failure therapy in children and why effective therapy is withheld.

Schranz D, Voelkel NF.

Eur J Pediatr. 2016 Apr;175(4):445-55. doi: 10.1007/s00431-016-2700-3. Epub 2016 Feb 19. Review.

13.

Addressing Major Unmet Needs in Patients with Systolic Heart Failure: The Role of Ivabradine.

Pereira-Barretto AC.

Am J Cardiovasc Drugs. 2016 Apr;16(2):93-101. doi: 10.1007/s40256-016-0159-2. Review.

14.

Cardiac Effects of Attenuating Gsα - Dependent Signaling.

Streit MR, Weiss CS, Meyer S, Ochs MM, Hagenmueller M, Riffel JH, Buss SJ, Heger T, Katus HA, Hardt SE.

PLoS One. 2016 Jan 26;11(1):e0146988. doi: 10.1371/journal.pone.0146988. eCollection 2016.

15.

Recent Patient Characteristics and Medications at Admission and Discharge in Hospitalized Patients With Heart Failure.

Arimura T, Miura S, Morito N, Shiga Y, Kitajima K, Morii J, Iwata A, Fujimi K, Yahiro E, Saku K.

J Clin Med Res. 2016 Feb;8(2):97-104. doi: 10.14740/jocmr2402w. Epub 2015 Dec 28.

16.

Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.

Tang CH, Wang CC, Chen TH, Hong CY, Sue YM.

J Am Heart Assoc. 2016 Jan 6;5(1). pii: e002584. doi: 10.1161/JAHA.115.002584.

17.

Circulating Procollagen Type III N-Terminal Peptide and Mortality Risk in African Americans With Heart Failure.

Mansour IN, Bress AP, Groo V, Ismail S, Wu G, Patel SR, Duarte JD, Kittles RA, Stamos TD, Cavallari LH.

J Card Fail. 2016 Sep;22(9):692-9. doi: 10.1016/j.cardfail.2015.12.016. Epub 2015 Dec 22.

PMID:
26721774
18.

Is cardiac resynchronisation therapy feasible, safe and beneficial in the very elderly?

Olechowski B, Sands R, Zachariah D, Andrews NP, Balasubramaniam R, Sopher M, Paisey J, Kalra PR.

J Geriatr Cardiol. 2015 Sep;12(5):497-501. doi: 10.11909/j.issn.1671-5411.2015.05.003.

19.

Factors associated with 30-day readmission of patients with heart failure from a Japanese administrative database.

Aizawa H, Imai S, Fushimi K.

BMC Cardiovasc Disord. 2015 Oct 24;15:134. doi: 10.1186/s12872-015-0127-9.

20.

Management of Patients Admitted with Acute Decompensated Heart Failure.

Krim SR, Campbell PT, Desai S, Mandras S, Patel H, Eiswirth C, Ventura HO.

Ochsner J. 2015 Fall;15(3):284-9. Review.

Items per page

Supplemental Content

Write to the Help Desk